CN109182495B - 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 - Google Patents
一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 Download PDFInfo
- Publication number
- CN109182495B CN109182495B CN201811071168.6A CN201811071168A CN109182495B CN 109182495 B CN109182495 B CN 109182495B CN 201811071168 A CN201811071168 A CN 201811071168A CN 109182495 B CN109182495 B CN 109182495B
- Authority
- CN
- China
- Prior art keywords
- probe
- gene chip
- bilateral
- goblet
- shaped ear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 92
- 230000002146 bilateral effect Effects 0.000 title claims abstract description 57
- 238000001514 detection method Methods 0.000 title claims abstract description 45
- 239000000523 sample Substances 0.000 claims abstract description 130
- 238000000034 method Methods 0.000 claims abstract description 28
- 206010014016 Ear malformation Diseases 0.000 claims abstract description 24
- 238000002493 microarray Methods 0.000 claims abstract description 11
- 239000002773 nucleotide Substances 0.000 claims description 30
- 125000003729 nucleotide group Chemical group 0.000 claims description 30
- 238000009396 hybridization Methods 0.000 claims description 28
- 238000005406 washing Methods 0.000 claims description 14
- 238000003908 quality control method Methods 0.000 claims description 12
- 239000011521 glass Substances 0.000 claims description 5
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002274 desiccant Substances 0.000 claims description 3
- 238000007037 hydroformylation reaction Methods 0.000 claims description 3
- 230000020477 pH reduction Effects 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 2
- 230000001079 digestive effect Effects 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 230000009089 cytolysis Effects 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 abstract description 7
- 238000003793 prenatal diagnosis Methods 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 3
- 230000036407 pain Effects 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 230000004907 flux Effects 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 36
- 108020004414 DNA Proteins 0.000 description 12
- 238000001179 sorption measurement Methods 0.000 description 12
- 210000003754 fetus Anatomy 0.000 description 11
- 206010010356 Congenital anomaly Diseases 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 210000005259 peripheral blood Anatomy 0.000 description 6
- 239000011886 peripheral blood Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 210000000959 ear middle Anatomy 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000026350 Inborn Genetic disease Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000036244 malformation Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
- 102100029019 Homeobox protein HMX1 Human genes 0.000 description 2
- 101000986308 Homo sapiens Homeobox protein HMX1 Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000883 ear external Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000001215 fluorescent labelling Methods 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 210000001699 lower leg Anatomy 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 210000000933 neural crest Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000004728 ear cartilage Anatomy 0.000 description 1
- 230000004577 ear development Effects 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001982 neural crest cell Anatomy 0.000 description 1
- 230000014390 neural crest cell migration Effects 0.000 description 1
- 210000001020 neural plate Anatomy 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 210000004949 second gill arch Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
检测结果 | 数量 | 预测结果 | 实际结果 |
阳性 | 42例 | 患有双侧杯状耳畸形 | 双侧杯状耳畸形 |
阴性 | 141例 | 未患有双侧杯状耳畸形 | 表型正常 |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811071168.6A CN109182495B (zh) | 2018-09-14 | 2018-09-14 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
PCT/CN2019/105454 WO2020052603A1 (zh) | 2018-09-14 | 2019-09-11 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片、试剂盒及基因芯片的应用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811071168.6A CN109182495B (zh) | 2018-09-14 | 2018-09-14 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109182495A CN109182495A (zh) | 2019-01-11 |
CN109182495B true CN109182495B (zh) | 2021-02-23 |
Family
ID=64911249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811071168.6A Active CN109182495B (zh) | 2018-09-14 | 2018-09-14 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN109182495B (zh) |
WO (1) | WO2020052603A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109182495B (zh) * | 2018-09-14 | 2021-02-23 | 张娇 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
CN113462768B (zh) * | 2021-07-29 | 2023-05-30 | 中国医学科学院整形外科医院 | 一种利用ddPCR检测小耳畸形患者ECR区域的拷贝数的引物及试剂盒 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103436609A (zh) * | 2013-08-13 | 2013-12-11 | 康盈创新生物技术(北京)有限公司 | 一种无创产前诊断先天性耳聋遗传病的方法 |
CN109182495B (zh) * | 2018-09-14 | 2021-02-23 | 张娇 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
-
2018
- 2018-09-14 CN CN201811071168.6A patent/CN109182495B/zh active Active
-
2019
- 2019-09-11 WO PCT/CN2019/105454 patent/WO2020052603A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN109182495A (zh) | 2019-01-11 |
WO2020052603A1 (zh) | 2020-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101974492B1 (ko) | 샘플 중 상이한 이수성의 존재 또는 부재를 결정하는 방법 | |
EP3444357B1 (en) | Noninvasive detection method for screening healthily-growing blastulas | |
CA3049442A1 (en) | Method for non-invasive prenatal screening for aneuploidy | |
JP6929778B2 (ja) | 着床前遺伝子スクリーニングにおける一塩基多型を用いた品質管理方法 | |
Hua et al. | Detection of aneuploidy from single fetal nucleated red blood cells using whole genome sequencing | |
CN109182495B (zh) | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 | |
Lan et al. | Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening | |
CN111235265B (zh) | 用于预测半侧颜面短小畸形发生概率的组合物的应用方法 | |
RU2719160C2 (ru) | Способы, носители и наборы для улучшенного анализа сравнительной геномной гибридизации | |
CN108676868A (zh) | 一组1型糖尿病标志物及其应用 | |
WO2020052602A1 (zh) | 一种用于无创产前评估半侧颜面短小综合征的基因芯片、试剂盒及基因芯片的应用方法 | |
CN103740827A (zh) | 胎儿dna芯片及其应用 | |
CN112760365B (zh) | 一种适用于产前无创的poag基因检测试剂盒及其检测方法 | |
CN112899360B (zh) | 一种检测特雷彻·柯林斯综合征发生概率的组合物的应用方法 | |
CN109735645A (zh) | 一种检测球形孢子丝菌的实时荧光pcr引物、探针及试剂盒 | |
CN116665774A (zh) | 一种家系全基因组单体型连锁分析方法、装置、存储介质和设备 | |
CN112662754B (zh) | 用于预测小耳畸形发生概率的组合物的应用方法 | |
CN104087671A (zh) | 一种用于检测人21号染色体数目的试剂盒 | |
CN115938481A (zh) | 一种基于靶向捕获和序列随机测序的通用型胚胎遗传变异检测技术方法和系统 | |
CN110993024B (zh) | 建立胎儿浓度校正模型的方法及装置与胎儿浓度定量的方法及装置 | |
CN112921092A (zh) | 导致hlrcc的延胡索酸酶基因的新致病突变位点 | |
CN107312867B (zh) | 诊断甲状腺功能减退的snp及其应用 | |
CN113981141B (zh) | 乙型肝炎感染患者和携带者血浆中的一组分子标志物及其用途 | |
CN110872620B (zh) | 一种用于产前无创诊断双侧杯状耳畸形的引物探针组件、试剂盒及其应用 | |
Peng et al. | Impact of In Vitro Cell Subculture on Mosaicism: Comparative Analysis of Chromosome Microarray and Karyotype Results |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230815 Address after: Room 12, Room 209, 2nd Floor, Building 10, Yard 2, Shangjialou Road, Chaoyang District, Beijing, 100028 Patentee after: Pan Asia Runkang (Beijing) Biotechnology Co.,Ltd. Address before: 1-4-901, Yongjing Siji, Xili, Xihuang village, Tiancun Road, Shijingshan District, Beijing Patentee before: Zhang Jiao |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240226 Address after: 210000 No.87 dingjiaqiao, Gulou District, Nanjing, Jiangsu Province Patentee after: Zhang Jiao Country or region after: China Address before: Room 12, Room 209, 2nd Floor, Building 10, Yard 2, Shangjialou Road, Chaoyang District, Beijing, 100028 Patentee before: Pan Asia Runkang (Beijing) Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |